Skip to content

Effects of pupil-dilating drug on myopia progression and intraocular pressure elevation

Effects of topical atropine on intraocular pressure and myopia progression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN33002849
Enrollment
60
Registered
2016-05-31
Start date
2009-05-01
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia in children Eye Diseases Myopia

Interventions

This is an interventional study that enrolled children with myopia. If the parents state a preference for their child to not receive any medications, they are assigned to the control group with specta

Sponsors

Chang Gung Memorial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Children in Northern Taiwan aged between 6 to 12 years. 2. Patients with a refractive error less than -3.0 diopters (D)

Exclusion criteria

Exclusion criteria: 1. Congenital eye disorder 2. Any disease influence the cornea, lens or retina 3. Best correct visual acuity<20/25 using the Snellen chart 4. Primary intraocular pressure above 21mmHg 5. Atropine application within 6 months before enrollment 6. Patients who could understand the details of this study or could not adhere to the follow up schedule

Design outcomes

Primary

MeasureTime frame
Myopia and its progression: with autorefractometer and manifest refraction by experienced technician. Assessed at baseline and then every 3 months for next 12 months.

Secondary

MeasureTime frame
IOP measurement: with pneumatic tonometer by experienced technician. Assessed at baseline and then every 3 months for next 12 months.

Countries

Taiwan

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 12, 2026